Cargando…
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
Autores principales: | Akima, Satoshi, McLintock, Claire, Hunt, Beverley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770917/ https://www.ncbi.nlm.nih.gov/pubmed/32302442 http://dx.doi.org/10.1111/jth.14853 |
Ejemplares similares
-
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020) -
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020) -
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022) -
Management of cancer‐associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement
por: Held, Nicole, et al.
Publicado: (2022) -
COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
por: Cannegieter, Suzanne C., et al.
Publicado: (2020)